{"title":"产后12个月内HIV护理保留相关因素:一项回顾性队列研究。","authors":"Tran Dang, Jean Anderson, Anna M Powell","doi":"10.1097/QAI.0000000000003593","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Loss to follow-up to HIV care following delivery puts birthing parents with HIV at higher risk of loss of viral suppression, disease progression, and HIV partner transmission. This study assessed factors associated with retention in postpartum HIV care.</p><p><strong>Methods: </strong>This is a retrospective cohort study at a single academic medical center and included patients followed from January 2014 to December 2022. The primary outcome was retention in postpartum HIV care (any healthcare encounter discussing HIV medication adherence or viral load within 12 months postpartum). Data was analyzed using Chi-square and student T-test for discrete and continuous variables. Univariate and multivariable log regressions were used to measure independent associations on care retention and healthcare utilization outcomes.</p><p><strong>Results: </strong>Of the 111 patients with planned follow up at our facility, 93 (83.8%) of participants had ≥ 1 HIV care encounter within 12 months of delivery. Participants had a mean age of 31.2 (± 5.84), were predominantly Black (79.3%), non-Hispanic (91%), non-U.S. born (57.5%) with substantial exposure of prior IPV (29.6%). Participants retained in care were more likely to use ART during pregnancy (92/99% vs 16/94.2%, P=0.01) and have viral suppression at delivery (n= 83/90% vs 12/67%, P=.02). Retention in care was negatively associated with substance use during pregnancy (aOR 0.29, 95% CI 0.09-0.95) following adjustment for social health covariates.</p><p><strong>Conclusion: </strong>While almost 84% of participants were retained in HIV care within 12 months of delivery, substance use in pregnancy was a significant risk factor for HIV care attrition postpartum.</p>","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Factors Associated with Retention in HIV Care within 12 months Postpartum: A Retrospective Cohort Study.\",\"authors\":\"Tran Dang, Jean Anderson, Anna M Powell\",\"doi\":\"10.1097/QAI.0000000000003593\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Loss to follow-up to HIV care following delivery puts birthing parents with HIV at higher risk of loss of viral suppression, disease progression, and HIV partner transmission. This study assessed factors associated with retention in postpartum HIV care.</p><p><strong>Methods: </strong>This is a retrospective cohort study at a single academic medical center and included patients followed from January 2014 to December 2022. The primary outcome was retention in postpartum HIV care (any healthcare encounter discussing HIV medication adherence or viral load within 12 months postpartum). Data was analyzed using Chi-square and student T-test for discrete and continuous variables. Univariate and multivariable log regressions were used to measure independent associations on care retention and healthcare utilization outcomes.</p><p><strong>Results: </strong>Of the 111 patients with planned follow up at our facility, 93 (83.8%) of participants had ≥ 1 HIV care encounter within 12 months of delivery. Participants had a mean age of 31.2 (± 5.84), were predominantly Black (79.3%), non-Hispanic (91%), non-U.S. born (57.5%) with substantial exposure of prior IPV (29.6%). Participants retained in care were more likely to use ART during pregnancy (92/99% vs 16/94.2%, P=0.01) and have viral suppression at delivery (n= 83/90% vs 12/67%, P=.02). Retention in care was negatively associated with substance use during pregnancy (aOR 0.29, 95% CI 0.09-0.95) following adjustment for social health covariates.</p><p><strong>Conclusion: </strong>While almost 84% of participants were retained in HIV care within 12 months of delivery, substance use in pregnancy was a significant risk factor for HIV care attrition postpartum.</p>\",\"PeriodicalId\":14588,\"journal\":{\"name\":\"JAIDS Journal of Acquired Immune Deficiency Syndromes\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-01-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAIDS Journal of Acquired Immune Deficiency Syndromes\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/QAI.0000000000003593\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003593","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:分娩后缺少艾滋病毒护理随访使携带艾滋病毒的分娩父母失去病毒抑制、疾病进展和艾滋病毒伴侣传播的风险更高。本研究评估了产后HIV护理中滞留的相关因素。方法:这是一项在单一学术医疗中心进行的回顾性队列研究,纳入了2014年1月至2022年12月随访的患者。主要结局是产后HIV护理的保留情况(产后12个月内任何讨论HIV药物依从性或病毒载量的医疗保健会面)。离散变量和连续变量的数据分析采用卡方检验和学生t检验。使用单变量和多变量对数回归来衡量护理保留和医疗保健利用结果的独立关联。结果:在我们医院计划随访的111例患者中,93例(83.8%)的参与者在分娩后12个月内有≥1次HIV护理经历。参与者的平均年龄为31.2岁(±5.84岁),主要是黑人(79.3%),非西班牙裔(91%),非美国裔。出生时大量暴露于IPV(29.6%)(57.5%)。保留护理的参与者更有可能在怀孕期间使用ART (92/99% vs 16/94.2%, P=0.01),分娩时病毒抑制(n= 83/90% vs 12/67%, P= 0.02)。在调整社会健康协变量后,护理留置与妊娠期间药物使用呈负相关(aOR 0.29, 95% CI 0.09-0.95)。结论:虽然几乎84%的参与者在分娩后12个月内继续接受艾滋病毒护理,但怀孕期间药物使用是产后艾滋病毒护理消耗的重要危险因素。
Factors Associated with Retention in HIV Care within 12 months Postpartum: A Retrospective Cohort Study.
Background: Loss to follow-up to HIV care following delivery puts birthing parents with HIV at higher risk of loss of viral suppression, disease progression, and HIV partner transmission. This study assessed factors associated with retention in postpartum HIV care.
Methods: This is a retrospective cohort study at a single academic medical center and included patients followed from January 2014 to December 2022. The primary outcome was retention in postpartum HIV care (any healthcare encounter discussing HIV medication adherence or viral load within 12 months postpartum). Data was analyzed using Chi-square and student T-test for discrete and continuous variables. Univariate and multivariable log regressions were used to measure independent associations on care retention and healthcare utilization outcomes.
Results: Of the 111 patients with planned follow up at our facility, 93 (83.8%) of participants had ≥ 1 HIV care encounter within 12 months of delivery. Participants had a mean age of 31.2 (± 5.84), were predominantly Black (79.3%), non-Hispanic (91%), non-U.S. born (57.5%) with substantial exposure of prior IPV (29.6%). Participants retained in care were more likely to use ART during pregnancy (92/99% vs 16/94.2%, P=0.01) and have viral suppression at delivery (n= 83/90% vs 12/67%, P=.02). Retention in care was negatively associated with substance use during pregnancy (aOR 0.29, 95% CI 0.09-0.95) following adjustment for social health covariates.
Conclusion: While almost 84% of participants were retained in HIV care within 12 months of delivery, substance use in pregnancy was a significant risk factor for HIV care attrition postpartum.
期刊介绍:
JAIDS: Journal of Acquired Immune Deficiency Syndromes seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide.
JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.